At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the age and credit for inventing it. The CRISPR patents are back in play. On ...
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...
The stigmatized idea could get a massive boost from “tech bros”—and some scientists are cheering them on. Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results